New Photo - BenDeLaCreme and Kennedy Davenport recall chaos after RuPaul's Drag Race All Stars 3 self-elimina...

EW's BINGE podcast welcomes AS3 legends to spill on the most shocking moment in All Stars herstory, Shangela's hilarious method acting, a neverbeforeseen 10minute cut of Davenport's Bitchelor performance, and what went down in that final jury deliberation. BenDeLaCreme and Kennedy Davenport recall chaos after RuPaul's Drag Race All Stars 3 selfelimination EW's BINGE podcast welcomes AS3 legends to spill on the most shocking moment in All Stars herstory, Shangela's hilarious method acting, a neverbeforeseen 10minute cut of Davenport's Bitchelor performance, and what went down in that final jury...

EW's BINGE podcast welcomes AS3 legends to spill on the most shocking moment in All Stars herstory, Shangela's hilarious method acting, a never-before-seen 10-minute cut of Davenport's Bitchelor performance, and what went down in that final jury deliberation.

BenDeLaCreme and Kennedy Davenport recall chaos after RuPaul's Drag Race All Stars 3 self-elimination

Joey Nolfi, senior writer at

Joey Nolfi is a senior writer at *. *Since 2016, his work at EW includes *RuPaul's Drag Race* video interviews, Oscars predictions, and more.

EW's editorial guidelines

July 14, 2021 2:57 p.m. ET

BenDeLaCreme eliminated herself from* RuPaul's Drag Race All Stars 3* because that's what? The gag of the season. Bedtime BD herself joins the latest episode of *EW's BINGE* podcast alongside fellow *AS3* legend Kennedy Davenport to discuss the aftermath of the most shocking exit in the show's herstory.

In the episode (listen above), DeLa reveals that the "meandering path" to the decision she made to eliminate herself from the competition wasn't something she'd planned from the beginning of the competition, but rather a seemingly cosmic alignment of queen energy. For starters, she got the Wite-Out she used to write her name on one of the lipsticks from her *AS3* cast mate Thorgy Thor, and the concept to write someone else's name over an existing stick sprung from a running joke she started with eventual season winner Trixie Mattel that would've involved writing "RuPaul" or "Michelle Visage" on the tube as a prank.

"There was this moment where I was like, ok, I've really established myself, people do see me as a frontrunner, I've broken some records, if I decide I'm not going to play by these rules, no one is going to be able to say that she gave up because she couldn't do it," DeLa remembers, while Davenport confirms that other moments organically "just led up" to the big, unplanned reveal. "It was kind of this perfect thing where, in this moment, I kind of was fed up with the conflict generating with that moment with Morgan [McMichaels], I saw that I'd actually already done what I needed to do, and these little moments clicked into place.... it felt like fate."

She says she was shocked that production didn't stop her from making the choice, and she's thankful they allowed it to play out as she wished. Still, she's unsure if she would've pulled the stunt the next time she won a lip-sync if she'd lost the duel against BeBe Zahara Benet.

"Who knows? Probably not. It was a thing that was relevant to the moment. Maybe I would've, but I don't dwell on pasts that don't exist," she finishes.

Davenport insists it was a "real moment" for her, too: "I was boo-hoo crying over there, honey," she says. "You know when it's your time to go home and that was really my time to go home. Had she not went home, I do believe I probably would've gone home that episode!"

Drag Race All Stars

Kennedy Davenport and BenDeLaCreme discuss shocking moments in EW's BINGE podcast 'RuPaul's Drag Race All Stars 3' recap. World of Wonder/ Paramount +

Other topics covered on this episode include:

- Shangela's hilarious method acting to get into character as Mariah Carey for the musical challenge

- Davenport's mini oral history on her iconic RuDemption chicken look that she insists is not a chicken (and which RuGirl purchased the piece after her original season)

- A call to "Release *The Bitchelor* Cut," as BenDeLaCreme and Davenport say there are 10-minute versions of their hilarious performances in the challenge (plus: they reveal what they did in those extra moments, too)

- Davenport pays tribute to her late friend and *RuPaul's Drag Race* icon Chi Chi DeVayne

- The circumstances surrounding the infamous Thorgy Thor note Trixie Mattel had in her station

- BenDeLaCreme discusses coming back to the show after self-eliminating for the finale deliberation (and shares tea on how the group might've felt voting for Davenport and Mattel versus Shangela)

- Davenport reveals that, after a period of tension, she and Mattel have had lovely conversations about repairing their relationship after an intense season

Tune in again next week as EW's BINGE welcomes Naomi Smalls, Monique Heart, and Manila Luzon for a full *RuPaul's Drag Race All Stars 4* recap. Listen to BenDeLaCreme and Kennedy Davenport discuss *All Stars 3* above.

***Subscribe to* EW's BINGE* podcast for full recaps of *RuPaul's Drag Race*, including our new season diving into all five *All Stars *seasons, featuring exclusive interviews with Jujubee, Alexis Mateo, Shea Couleé, Alaska, Detox, BenDeLaCreme, Kennedy Davenport, and more*. *And be sure to catch up on our *BINGE* recaps of *RuPaul's Drag Race* seasons 1-13 with Symone, Jaida Essence Hall, Trixie Mattel, Katya, Peppermint, Bianca Del Rio, Bob the Drag Queen, Sasha Velour, and more******!***

**Related content: **

- Alaska and Detox spill *RuPaul's Drag Race All Stars 2* tea on the moment that almost saved Alyssa Edwards

- Jujubee and Alexis Mateo reveal who else almost quit *RuPaul's Drag Race All Stars 1*

- Yara Sofia was breast in show on *RuPaul's Drag Race All Stars 6* — and we love it

- EW's Binge Podcast Episodes

Original Article on Source

Source: "EW EW"

Source: EW

Published: November 03, 2025 at 12:19PM on Source: ONEEL MAG

#ShowBiz#Sports#Celebrities#Lifestyle

byLiam Oneel

in

November 03, 2025

BenDeLaCreme and Kennedy Davenport recall chaos after RuPaul's Drag Race All Stars 3 self-elimina...

EW's BINGE podcast welcomes AS3 legends to spill on the most shocking moment in All Stars herstory, Shangela's hilari...

New Photo - Vampire Diaries creators talk season 1's Katherine twist, the fan response that left them 'aghast'

There was one particular Damon moment that backfired on the writers. Vampire Diaries creators talk season 1's Katherine twist, the fan response that left them 'aghast' There was one particular Damon moment that backfired on the writers. By Samantha Highfill :maxbytes(150000):stripicc()/SamanthaHighfillauthorphoto0917254112e875604542d49744a27de908d183.jpg) Samantha Highfill Samantha Highfill is an executive editor at , where she's worked for more than 12 years covering television. EW's editorial guidelines August 4, 2021 9:00 a.m. ET Every story needs a good villain.

There was one particular Damon moment that backfired on the writers.

Vampire Diaries creators talk season 1's Katherine twist, the fan response that left them 'aghast'

There was one particular Damon moment that backfired on the writers.

By Samantha Highfill

Sam Highfill author photo

Samantha Highfill

Samantha Highfill is an executive editor at **, where she's worked for more than 12 years covering television.

EW's editorial guidelines

August 4, 2021 9:00 a.m. ET

Every story needs a good villain. And for the beginning of *The Vampire Diaries*, Damon Salvatore (Ian Somerhalder) was that villain, the big bad brother who followed Stefan (Paul Wesley) home to Mystic Falls to make his life — or eternity — miserable. (And then there was Damon's whole plan to free the series' next villain from a tomb that she wasn't actually in, but we'll get to that.)

In the early days of the series, *Vampire Diaries* co-creators Kevin Williamson and Julie Plec worked to discover Damon's voice, finding inspiration from within. "It's just that inner voice that is so snarky, all the things you wanna say out loud but you can't," Williamson says during episode 1 of *EW's Binge: The Vampire Diaries*.

The result was an arrogant (and glib) Salvatore who delivered a handful of enigmatic one-liners in season 1, including Plec's personal favorite: Standing on a roof, Damon refuses to tell Stefan his evil master plan. When asked what he's up to, he responds, "That's for me to know and you to dot dot dot." And it turns out, that line was Plec and Williamson's way of answering a network note... or 10.

"For the first three or four episodes, any time anyone read a script at the network they were like, 'Yes, but what's Damon's drive? What does Damon want?' And we were like, 'Oh my God, he just wants to be an a--hole,'" Plec says with a laugh.

So, the writers worked it into the script, with Stefan serving as the voice of the network, constantly asking the same question: What does Damon want? Until, finally, Damon tells him that it's "for me to know and you to dot dot dot." (Get it?)

But as season 1 continued, fans started to fall for Damon's evil ways a bit too much, so much so that Williamson and Plec felt the need to reset some things at the start of season 2. "We can't have a lovable villain," says Williamson. "That's great and that's a fan-favorite character, but that doesn't bring you real storytelling and real stakes."

Plec adds, "We had this magnificent villain who could do no wrong in the eyes of the audience and we thought, 'Let's give him something really wrong that is unforgivable so we can buy ourselves another year of Damon as the villain and Stefan as the hero.'" With that in mind, they had Damon snap Jeremy's (Steven R. McQueen) neck at the end of the season 2 premiere. But the fan response was not what Plec and Williamson had intended.

"They [were like], 'Poor Damon, poor Damon, he's so misunderstood! He just loves Elena so much,'" Plec recalls. "We were aghast. We were like, 'What have we wrought? We have basically accidentally created the poster couple for toxic masculinity.' The women loved him and we couldn't understand it at all. That was a moment."

Thankfully, Damon wasn't the show's only villain by that point. As Williamson puts it, "Every time one of the villains turned nice, we brought in a new one." And that's just what happened at the end of season 1, when, in one of the series' biggest twists, Katherine Pierce (Nina Dobrev) shows up, kisses Damon, and then waltzes into Elena's house and removes Uncle John's (David Anders) fingers.

The Vampire Diaries

Nina Dobrev as Katherine Pierce on 'The Vampire Diaries.'. The CW

"That set the standard for *Vampire Diaries*," Plec says of the season 1 finale twist. "That finale set the standard of: We always have to fight to get to as close to this amazing awesome twist and cliffhanger ending as we possibly can. We can never let our audience down with a finale. We put so much pressure on ourselves for eight years to make sure that we never failed a finale. There were some that were better than others, but we took our finales seriously."

And to think, it wasn't always the plan for Dobrev to play both characters. "It didn't occur to us originally that Nina should play Elena and Katherine," Plec says of what would become the Petrova doppelgangers. "In the books, they called it a striking resemblance. I remember Italia Ricci, who had tested for Elena early on, comes up to us at Comic-Con after the show gets picked up she's like, 'I am putting myself in front of you to say I would like to play Katherine Pierce.'"

But by that point, Dobrev's photo had already been used for the 1864 snapshot of the curly-haired doppelganger, and a few episodes later, she'd take on both roles and nothing in Mystic Falls would ever be the same.

Listen to the full podcast episode below and stream all eight seasons of *The Vampire Diaries *on Netflix.

**To listen, subscribe to *EW's Binge: The Vampire Diaries* feed via Apple Podcasts, Spotify, or wherever you get your podcasts. You can also subscribe to EW's YouTube page to catch all the video interviews, and stay tuned to EW.com.**

**Related content:**

- We drank three rounds with *Vampire Diaries *stars Paul Wesley and Ian Somerhalder

- Today will be different: An oral history of* The Vampire Diaries* pilot

- Best. of the Decade: *The Vampire Diaries* delivered a perfect love triangle in its third season

- EW's Binge Podcast Episodes

Original Article on Source

Source: "EW EW"

Source: EW

Published: November 03, 2025 at 12:19PM on Source: ONEEL MAG

#ShowBiz#Sports#Celebrities#Lifestyle

byLiam Oneel

in

November 03, 2025

Vampire Diaries creators talk season 1's Katherine twist, the fan response that left them 'aghast'

There was one particular Damon moment that backfired on the writers. Vampire Diaries creators talk season 1's Kather...

If You'd Invested $1,000 in Nvidia 5 Years Ago, Here's How Much You'd Have Today Keith Noonan, The Motley FoolNovember 3, 2025 at 1:38 AM 0 Key Points Nvidia started as a tech specialist focused on gaming GPUs, but its strength in the category gave way to huge growth opportunities. Nvidia's leadership in advanced GPUs gave it a big lead in AI processing. The company's wins in AI have translated into incredible gains for shareholders over the last five years. 10 stocks we like better than Nvidia › Nvida (NASDAQ: NVDA) has gone through an incredible transformation over the last five years.

- - If You'd Invested $1,000 in Nvidia 5 Years Ago, Here's How Much You'd Have Today

Keith Noonan, The Motley FoolNovember 3, 2025 at 1:38 AM

Key Points -

Nvidia started as a tech specialist focused on gaming GPUs, but its strength in the category gave way to huge growth opportunities.

Nvidia's leadership in advanced GPUs gave it a big lead in AI processing.

The company's wins in AI have translated into incredible gains for shareholders over the last five years.

10 stocks we like better than Nvidia ›

Nvida (NASDAQ: NVDA) has gone through an incredible transformation over the last five years. In 2020, revenue from the company's data center segment began eclipsing revenue from its gaming segment for the first time. Strikingly, the core architecture of its graphics-processing units for both gaming and data centers wasn't wildly different.

It just so happened that the GPU technologies it had developed for gaming could be adjusted and made more powerful in order to carry out complex computations for distributed computing run through data centers. The company's expertise in high-end GPUs also gave it perfect positioning to dominate the artificial intelligence (AI) hardware revolution and deliver incredible returns for shareholders.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

An Nvidia sign outside of one of the company's buildings.

Image source: Nvidia.

Nvidia stock has delivered life-changing returns

Over the past five years, Nvidia stock has delivered a dividend-adjusted total return of roughly 1,490%. With that level of return, investors who took a buy-and-hold approach to the stock on this day five years ago with a $1,000 investment would now own a position worth more than $15,900. j

Nvidia recently became the first company to reach a $5 trillion market capitalization, and it could wind up holding on to its position as the world's most valuable business for the foreseeable future. The key to the company's incredible valuation gains has been its leadership in the advanced AI processor space, and there's little indication that it will be losing this advantage anytime soon.

Should you invest $1,000 in Nvidia right now?

Before you buy stock in Nvidia, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $603,392!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,241,236!*

Now, it's worth noting Stock Advisor's total average return is 1,072% — a market-crushing outperformance compared to 194% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of October 27, 2025

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.

Original Article on Source

Source: "AOL Money"

Source: Money

Published: November 03, 2025 at 12:18PM on Source: ONEEL MAG

#ShowBiz#Sports#Celebrities#Lifestyle

byLiam Oneel

in

November 03, 2025

If You'd Invested $1,000 in Nvidia 5 Years Ago, Here's How Much You'd Have Today

If You'd Invested $1,000 in Nvidia 5 Years Ago, Here's How Much You'd Have Today Keith Noonan, The Motley...

Prediction: The Next Eli Lilly Might Already Be Trading Under $50 Prosper Junior Bakiny, The Motley FoolNovember 3, 2025 at 1:45 AM 0 Key Points Viking Therapeutics is developing a weight loss medicine in the same general class as Eli Lilly's tirzepatide. The midcap biotech is exploring options for a potential quadruple agonist therapy. Though Viking looks promising, there are also significant risks involved.

- - Prediction: The Next Eli Lilly Might Already Be Trading Under $50

Prosper Junior Bakiny, The Motley FoolNovember 3, 2025 at 1:45 AM

Key Points -

Viking Therapeutics is developing a weight loss medicine in the same general class as Eli Lilly's tirzepatide.

The mid-cap biotech is exploring options for a potential quadruple agonist therapy.

Though Viking looks promising, there are also significant risks involved.

10 stocks we like better than Viking Therapeutics ›

Eli Lilly (NYSE: LLY) produced exceptional returns over the long run and is now the largest pharmaceutical company in the world by market cap, largely thanks to its work in diabetes drugs and, more recently, weight management. The company's shares are currently trading at about $860, but what if we could invest in the next Eli Lilly now at a fraction of that price?

One strong candidate for future pharmaceutical greatness is Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech with large-cap ambitions.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Trying to emulate a giant

Viking Therapeutics doesn't have any products on the market yet, but its leading drug candidate, VK2735, looks promising. This investigational weight loss medicine mimics the actions of the GLP-1 and GIP hormones, both of which help control blood sugar levels. So far, the only dual GLP-1/GIP agonist approved by the Food and Drug Administration is Eli Lilly's tirzepatide, a therapy that is smashing pharmaceutical industry sales records, marketed as Mounjaro and Zepbound.

Patient self-administering a shot.

Image source: Getty Images.

Will VK2735 follow a similar path? It's still a bit early to say, but targeting two hormonal pathways (instead of just one) is clearly a promising approach. The biotech is running a phase 3 study for a subcutaneous version of VK2735, and recently completed phase 2 trials for an oral formulation of the therapy. The data was mixed -- at least that's the impression one might get from the market's reaction after it was published.

The efficacy of oral VK2735 was strong, but investors worried about the relatively high rates of adverse reactions, which led to significant rates of dropouts from the study. The medicine still looks promising, though. Lower doses of oral VK2735 led to fewer adverse reactions while still demonstrating attractive levels of efficacy at 13 weeks, and patients could, in theory, gradually increase their dosages to help mitigate side effects. In short, both the oral and subcutaneous versions of VK2735 are exciting candidates that could earn regulatory approval within a few years and take a slice of the fast-growing weight management therapy market.

Meanwhile, Viking Therapeutics is developing other therapies, too. It has another weight loss candidate in preclinical studies that targets two other hormones: amylin, which helps control blood sugar and satiety, and calcitonin, which regulates calcium levels in the blood. The biotech plans to request regulatory approval to start clinical trials for it in early 2026.

The biotech could, eventually, try to combine VK2735 with this newer medicine to target four different hormones. This approach could significantly boost the overall efficacy of these weight loss treatments.

Viking Therapeutics is also working on another therapy, VK2809, which performed well in phase 2 studies as a treatment for metabolic dysfunction-associated steatohepatitis, a liver disease.

A promising future, but a risky investment

Eli Lilly and Novo Nordisk are the leaders in the weight management drug market. Few rivals have thus far delivered mid-stage clinical trial results that seem to put their candidate drugs on a path to challenge that dominance. However, Viking Therapeutics is one of them. And over the coming quarters, the company's shares could rise significantly as it makes progress and eventually earns approval for VK2735, if it gets that far.

However, investing in clinical-stage biotech companies almost always carries significant risk. That's true in Viking Therapeutics' case as well, although it has a better profile than similarly sized peers.

For example, VK2735 could fail to show any statistically significant improvements in patients' weight in phase 3 studies, despite its strong performance in mid-stage trials. Or, that data could show clinically meaningful results, but not results that are strong enough to make VK2735 a commercially viable option compared to the widely used tirzepatide and semaglutide. And that's to say nothing of Viking Therapeutics' candidate that is still in preclinical trials.

The biotech has shown great innovative qualities for a company of its size so far, and if everything goes according to plan, it could become a leading biotech in the next decade. But things could go wrong, and if they do, Viking Therapeutics might not even exist in 10 years. So, investors should keep that in mind before buying the company's shares, which trade at about $38 apiece at the time of this writing. Only investors who are comfortable with risk should consider initiating a position in Viking Therapeutics.

Should you invest $1,000 in Viking Therapeutics right now?

Before you buy stock in Viking Therapeutics, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

See the 10 stocks »

*Stock Advisor returns as of October 27, 2025

Prosper Junior Bakiny has positions in Eli Lilly, Novo Nordisk, and Viking Therapeutics. The Motley Fool recommends Novo Nordisk and Viking Therapeutics. The Motley Fool has a disclosure policy.

Original Article on Source

Source: "AOL Money"

Source: Money

Published: November 03, 2025 at 12:18PM on Source: ONEEL MAG

#ShowBiz#Sports#Celebrities#Lifestyle

byLiam Oneel

in

November 03, 2025

Prediction: The Next Eli Lilly Might Already Be Trading Under $50

Prediction: The Next Eli Lilly Might Already Be Trading Under $50 Prosper Junior Bakiny, The Motley FoolNovember 3, 2025...

Is Berkshire Hathaway Stock a Buy Now? Leo Sun, The Motley FoolNovember 3, 2025 at 1:40 AM 0 Key Points Berkshire Hathaway is a reliable longterm investment. Its longtime CEO, Warren Buffett, will step down by the end of the year. It should continue to grow as long as Greg Abel sticks to Buffett's playbook. 10 stocks we like better than Berkshire Hathaway › Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has been an incredible longterm investment.

- - Is Berkshire Hathaway Stock a Buy Now?

Leo Sun, The Motley FoolNovember 3, 2025 at 1:40 AM

Key Points -

Berkshire Hathaway is a reliable long-term investment.

Its longtime CEO, Warren Buffett, will step down by the end of the year.

It should continue to grow as long as Greg Abel sticks to Buffett's playbook.

10 stocks we like better than Berkshire Hathaway ›

Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has been an incredible long-term investment. After taking over the struggling textile maker in 1965, Warren Buffett transformed the company into a diversified conglomerate that had a compound annual growth rate (CAGR) of nearly 20% over the following six decades.

That rally would have turned $1,000 into $55 million. The same investment in the S&P 500, which had a CAGR of 10% over the same period, would be worth about $390,000.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

But as Buffett gets ready to retire by the end of the year, is Berkshire's stock still worth buying? Let's review its business model and future challenges to decide.

Berkshire Hathaway CEO Warren Buffett.

Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.

Understanding Berkshire's business model

Berkshire Hathaway owns a mix of insurance, railroad, energy, manufacturing, retail, and consumer staples companies. Its top subsidiaries include GEICO, the utility PacifiCorp, the BNSF Railway, Duracell, the Nebraska Furniture Mart, See's Candies, Dairy Queen, and Fruit of the Loom. Most of those companies generate plenty of cash and are well insulated from economic downturns.

Berkshire Hathaway also owns a portfolio of stocks worth about $313 billion, or 30% of its entire market cap of $1.03 trillion, as of this writing. Its top holdings include blue chip giants like Apple, American Express, Bank of America, Coca-Cola, and Chevron. Many investors follow that list for long-term investment ideas that were personally approved by the Oracle of Omaha.

It's tough to keep track of all of Berkshire's moving parts, but its growth can be measured with two key metrics: its float (the amount of cash from its insurance subsidiaries' premiums that can be deployed on investments before claims are paid) and its operating earnings (which exclude the volatile gains or losses from its equity portfolio). Both metrics grew over the past three years -- even as inflation, rising rates, and other macro headwinds rattled the market.

Metric

2022

2023

2024

Year-end float

$164 billion

$169 billion

$171 billion

Operating earnings

$31 billion

$37 billion

$47 billion

Data source: Berkshire Hathaway.

Berkshire continued to grow in that challenging environment for three reasons. First, its insurance business is well insulated from economic downturns because those customers generally won't cancel their policies just to save a few dollars. Second, its railroad, manufacturing, and utility businesses have wide moats and plenty of pricing power. Lastly, rising rates actually boosted the yields of its short-term Treasuries, which it's been hoarding over the past few years.

From 2022 to 2024, Berkshire's year-end cash, cash equivalents, and short-term Treasuries surged from $128 billion to $334 billion. That total rose to $340 billion in the second quarter of 2025. That gain was driven by its liquidation of some stocks and a decision to pause its buybacks in 2024.

What challenges does Berkshire Hathaway face?

Buffett's decision to trim some of Berkshire's top holdings, hoard more cash and T-bills, and pause its buybacks all suggested the market was getting overheated. That's certainly true: The S&P 500 is hovering near its record high and looks historically expensive at 32 times earnings.

Yet the stock still looks reasonably valued at 22 times last year's operating earnings. If we turn the clock back to the end of 2022, it was also trading at about 22 times its trailing operating earnings -- but its stock has rallied more than 50% since then.

Berkshire's valuations probably aren't overheating in this frothy market because it faces some unpredictable challenges. First and foremost, its longtime investors are probably worried that Buffett's successor, Berkshire Hathaway Energy's current CEO Greg Abel, won't stick to the Oracle's playbook of steadily growing its float and investing in stable blue-chip stocks.

The company's growing cash hoard (now sitting at $382 billion) suggests it's running out of fresh ways to expand its core subsidiaries or investment portfolio. That's a prudent move in a pricey market, but sticking to that conservative strategy might cause it to underperform the S&P 500 over the next few years.

Is it the right time to buy Berkshire Hathaway's stock?

Berkshire Hathaway's stock might trade sideways over the next year as Abel takes the helm. But if he sticks to Buffett's time-tested strategies, it should still grow its float and operating earnings as it prunes or expands its stock portfolio. Simply put, it's still a rock-solid buy, but investors shouldn't expect any huge near-term gains.

Should you invest $1,000 in Berkshire Hathaway right now?

Before you buy stock in Berkshire Hathaway, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

See the 10 stocks »

*Stock Advisor returns as of October 27, 2025

Bank of America is an advertising partner of Motley Fool Money. American Express is an advertising partner of Motley Fool Money. Leo Sun has positions in Apple and Berkshire Hathaway. The Motley Fool has positions in and recommends Apple, Berkshire Hathaway, and Chevron. The Motley Fool has a disclosure policy.

Original Article on Source

Source: "AOL Money"

Source: Money

Published: November 03, 2025 at 12:18PM on Source: ONEEL MAG

#ShowBiz#Sports#Celebrities#Lifestyle

byLiam Oneel

in

November 03, 2025

Is Berkshire Hathaway Stock a Buy Now?

Is Berkshire Hathaway Stock a Buy Now? Leo Sun, The Motley FoolNovember 3, 2025 at 1:40 AM 0 Key Points Berkshire Hathaway...

Is TransCrypts Riding the Next Wave of AI Infrastructure? 3 Reasons Tech Investors Will Want to Keep an Eye on This Startup. Emma Newbery, The Motley FoolNovember 3, 2025 at 12:45 AM 0 Key Points TransCrypts gives people control of their digital identities. Criminals are using AI to create sophisticated imitations of people and commit fraud. Blockchain technology offers a new model for online data security. 10 stocks we like better than Equifax › Artificial intelligence (AI) and blockchain technology are two big trends that are already impacting the way we live and work.

- - Is TransCrypts Riding the Next Wave of AI Infrastructure? 3 Reasons Tech Investors Will Want to Keep an Eye on This Startup.

Emma Newbery, The Motley FoolNovember 3, 2025 at 12:45 AM

Key Points -

TransCrypts gives people control of their digital identities.

Criminals are using AI to create sophisticated imitations of people and commit fraud.

Blockchain technology offers a new model for online data security.

10 stocks we like better than Equifax ›

Artificial intelligence (AI) and blockchain technology are two big trends that are already impacting the way we live and work. But both bring their own challenges, particularly in terms of security, trust, and identity. That's where tech start-up TransCrypts comes in. It operates a verification platform that puts users in charge of their own data, and it could change the way all kinds of background and identity checks work.

Pantera Capital just led a $15 million round of seed funding for TransCrypts, gaining support from Lightspeed Faction, Alpha Edison, Motley Fool Ventures, California Innovation Fund, Mark Cuban, Techstars, Alumni Ventures, and others.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

The digital identity field is worth following, as this type of security is a growing concern for many people. Plus, tracking early-stage companies can be a good way to gain more insights about their fundamentals long before they decide to go public. Here are three reasons to keep privately held TransCrypts on your radar.

Robotic hand holds graphic of a head with an AI brain.

Image source: Getty Images.

1. Identity theft is on the rise

The Motley Fool's research into identity theft shows that 2025 could see a record number of cases. Indeed, per Javelin Strategy, U.S. consumers lost over $27 billion to identity theft last year -- up 19% from the year before. Unfortunately, technological change has outpaced security improvements, leaving new vulnerabilities for criminals to exploit.

Moreover, AI tools enable ever more sophisticated phishing attacks. The ability to rapidly produce deepfake content allows fraudsters to easily impersonate victims' family members, business employees, or customer service operators from banks or brokerages. Traditional online security methods aren't necessarily enough anymore. TransCrypts uses cryptographic verification, combined with the security of the blockchain, to ensure that your identity can't be manipulated or forged.

2. Blockchains offer real-time, user-controlled verification

The power of blockchain-based identity verification is that it shifts control of personal data from big corporations to individuals. The idea is central to Web3, which many see as the next evolution of the internet. With online fraud on the up and AI supercharging criminals' abilities to imitate us online, the TransCrypts team believes that the immutable ledgers created by blockchains are part of the answer.

"AI is creating a world where we need to verify information and identity in real time," TransCrypts founder and CEO Zain Zaidi told The Motley Fool. "The only way to do that is consumer-empowered verifications. Relying on any third party to verify identities is compliance-laden and too slow. TransCrypts' consumer-empowered credentials allow anyone to verify who they are, that they are human, and their credentials."

TransCrypts started with employment data, and the money raised in its recent funding round will support its expansion into health data, education records, and more. Cutting out the middleman via the blockchain reduces the risk of data leaks. Authorization is immediate, and people's most sensitive information doesn't leave their control.

3. TransCrypts could fundamentally change the credit reporting system

The credit reporting system has gone through many transformations over the decades. At heart, what companies like Equifax (NYSE: EFX), TransUnion (NYSE: TRU), and Experian (LSE: EXPN) do is to collate data on consumers' financial histories and put it together into credit reports. TransCrypts could disrupt that model, giving individuals control over their financial information rather than credit bureaus.

It is an industry that's ripe for change, and if TransCrypts could take even a small segment of the market, it would be powerful. Allied Market Research recently said the credit bureau market was worth almost $125 billion in 2023, and forecast that it could reach over $385 billion by 2032. In terms of demand, not only did an Equifax data breach in 2017 expose the data of almost 150 million people, but in 2021, a Consumer Reports study found errors in over a third of credit reports.

We're facing a digital identity crisis

The digital identity space will become increasingly important as AI gets better and better at appearing to be human. There are a number of projects in this space, from cybersecurity to compliance companies. OpenAI founder Sam Altman even launched a crypto called Worldcoin that requires those who want to acquire the coin to get iris scans to verify that they are real humans and create their "WorldID."

TransCrypts has attracted an impressive lineup of early-stage investors. It has also already developed a successful product for background and employment checks, showing its model works. However, it may face challenges in the form of regulation, adoption, and competition.

One challenge for disruptive tech solutions is that incumbent players aren't always so easy to dethrone. As we've seen with cryptocurrencies and traditional finance, established companies are also integrating blockchain technology into their operations. In TransCrypts' case, both Equifax and TransUnion have announced partnerships to bring identity and credit data on-chain.

For investors, it will be worth monitoring these trends and solutions. Not only could it impact your portfolio if TransCrypts goes public, but it may also affect your long-term view of the industries TransCrypts could disrupt.

Should you invest $1,000 in Equifax right now?

Before you buy stock in Equifax, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Equifax wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

See the 10 stocks »

*Stock Advisor returns as of October 27, 2025

Emma Newbery has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Equifax. The Motley Fool recommends Experian Plc. The Motley Fool has a disclosure policy.

Original Article on Source

Source: "AOL Money"

Source: Money

Published: November 03, 2025 at 11:18AM on Source: ONEEL MAG

#ShowBiz#Sports#Celebrities#Lifestyle

byLiam Oneel

in

November 03, 2025

Is TransCrypts Riding the Next Wave of AI Infrastructure? 3 Reasons Tech Investors Will Want to Keep an Eye on This Startup.

Is TransCrypts Riding the Next Wave of AI Infrastructure? 3 Reasons Tech Investors Will Want to Keep an Eye on This ...

Here Are All 46 Stocks Warren Buffett Holds for Berkshire Hathaway's $313 Billion Portfolio Justin Pope, The Motley FoolNovember 3, 2025 at 12:50 AM 0 Key Points Buffett will soon retire as CEO of Berkshire Hathaway after decades of success. The company's portfolio illustrates some of Buffett's key philosophies and best stock ideas. Buffett's decision to accumulate so much cash in recent years will be a fascinating topic years from now. 10 stocks we like better than Berkshire Hathaway › Wall Street will soon enter a new era.

- - Here Are All 46 Stocks Warren Buffett Holds for Berkshire Hathaway's $313 Billion Portfolio

Justin Pope, The Motley FoolNovember 3, 2025 at 12:50 AM

Key Points -

Buffett will soon retire as CEO of Berkshire Hathaway after decades of success.

The company's portfolio illustrates some of Buffett's key philosophies and best stock ideas.

Buffett's decision to accumulate so much cash in recent years will be a fascinating topic years from now.

10 stocks we like better than Berkshire Hathaway ›

Wall Street will soon enter a new era.

That will occur in January, when multi-billionaire and investing legend Warren Buffett retires from his post as CEO of Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) at the end of 2025. It marks the end of a decades-long career, leading the famous holding company to become one of the world's largest corporations.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

Investors have long followed Buffett and team's stock picks via a massive portfolio within Berkshire Hathaway. Today, that portfolio spans 46 individual stocks, worth approximately $313 billion as of the latest regulatory filings.

Here is a dive into what Berkshire Hathaway currently owns, as well as a controversial Buffett decision that investors could debate for years to come.

Buying or selling Berkshire Hathaway on a smartphone.

Image source: Getty Images.

The 46 stocks in Berkshire Hathaway's $313 billion portfolio, listed in tiersBuffett's favorites, the core holdings

One thing that immediately stands out is that Buffett isn't afraid to lean into a winning idea. Berkshire Hathaway maintains a diversified portfolio, but Buffett has concentrated on his favorite ideas. As a result, Berkshire Hathaway's 10 largest holdings total approximately 82.1% of the portfolio.

Rank

Company Name

Position Value

Portfolio Weight (%)

Apple

$75.9B

24.2%

American Express

$54.6B

17.4%

Bank of America

$32.2B

10.3%

Coca-Cola

$27.6B

8.8%

Chevron

$18.8B

Moody's

$11.8B

3.8%

Occidental Petroleum

$10.9B

3.5%

Mitsubishi

$9.3B

Kraft Heinz

$8.0B

2.6%

10.

Itochu

$7.8B

2.5%

Source: All data per 13F and associated regulatory filings current through Aug. 14, 2025. Position values and portfolio weights are rounded.

You'll find that Berkshire Hathaway has held some of these stocks, such as American Express and Coca-Cola, for decades. It shows that holding on to your winning stocks can continue to have a positive impact on your portfolio over time.

Additionally, Buffett has famously favored dividend stocks. He has made it clear that he enjoys dividends, even if he opted against Berkshire Hathaway paying one, preferring to reinvest the company's earnings instead.

Diversification at work

Once you get through the top 10, you'll find a wide range of smaller positions across various industries, including insurance, financial services, technology, consumer products, and more. These 14 stocks account for approximately 14.8% of Berkshire's portfolio.

Rank

Company Name

Position Value

Portfolio Weight (%)

11.

Chubb Limited

$7.5B

2.4%

12.

Mitsui & Co

$7.2B

2.3%

13.

DaVita

$3.9B

1.2%

14.

Marubeni

$3.8B

1.2%

15.

Sumitomo

$3.4B

1.1%

16.

Kroger

$3.3B

17.

Sirius XM Holdings

$2.9B

0.9%

18.

Visa

$2.9B

0.9%

19.

Amazon

$2.2B

0.7%

20.

Mastercard

$2.2B

0.7%

21.

VeriSign

$2.1B

0.7%

22.

UnitedHealth Group

$1.7B

0.6%

23.

Constellation Brands

$1.7B

0.6%

24.

Capital One Financial

$1.6B

0.5%

Source: All data per 13F and associated regulatory filings current through Aug. 14, 2025. Position values and portfolio weights are rounded.

You'll find some of Berkshire's recent purchases in this group. The company invested in Chubb Limited in 2023 and in UnitedHealth Group earlier this year, after its controversy-driven tumble. Buffett has publicly discussed missing out on e-commerce giant Amazon, though a couple of Buffett's investment managers at Berkshire Hathaway eventually added the stock as a relatively minor position.

Spreading capital across various small bets

The remainder of the portfolio amounts to just 3% of Berkshire Hathaway's holdings, but don't dismiss them! Their cumulative value is just shy of $10 billion. Even the small positions matter when you manage this much capital.

Rank

Company Name

Position Value

Portfolio Weight (%)

25.

Aon PLC

$1.3B

0.4%

26.

Ally Financial

$1.1B

0.4%

27.

Domino's Pizza

$1.1B

0.3%

28.

Nucor

$1.0B

0.3%

29.

Liberty Live (Series C)

$1.0B

0.3%

30.

Pool Corp

$1.0B

0.3%

31.

Lennar (Class A)

$0.9B

0.3%

32.

Louisiana-Pacific

$0.5B

0.2%

33.

Liberty Live (Series A)

$0.4B

0.1%

34.

Heico (Class A)

$0.3B

0.1%

35.

Liberty Formula One (Series C)

$0.3B

0.1%

36.

Charter Communications

$0.2B

0.1%

37.

D.R. Horton

$0.2B

0.1%

38.

Lamar Advertising

$0.1B

39.

Allegion

$0.1B

40.

<$0.1B

41.

Jefferies Financial Group

<$0.1B

42.

Lennar (Class B)

<$0.1B

43.

Diageo

<$0.1B

44.

Liberty Latin America (Series A)

<$0.1B

45.

Liberty Latin America (Series C)

<$0.1B

46.

Atlanta Braves Holdings (Series C)

<$0.1B

Source: All data per 13F and associated regulatory filings current through Aug. 14, 2025. Position values and portfolio weights are rounded.

Berkshire Hathaway's cash position is remarkable, but is it a good strategy?

One glaring omission from Berkshire Hathaway's portfolio is its tremendous cash position. Buffett has been accumulating cash on Berkshire Hathaway's balance sheet for years. The company currently has $344.1 billion in cash, more than the market value of its entire stock portfolio and enough to buy most of the companies in the S&P 500 index outright.

Warren Buffett.

Image source: The Motley Fool.

Buffett is renowned for his patience and discipline in avoiding paying more for a stock than he believes it is worth. I'm in no position to question Buffett, I mean, who is? That said, it will be fascinating to look back on Buffett's cash accumulation over the past few years to see what might have been.

It's crucial to remember that managing hundreds of billions of dollars is a high-stakes endeavor, so risk management is paramount. For most individual investors, the best strategy is usually to dollar-cost average and stay invested. It doesn't hurt to have some cash on hand for opportunities, but as the famous saying goes, "Time in the market beats timing the market."

Should you invest $1,000 in Berkshire Hathaway right now?

Before you buy stock in Berkshire Hathaway, consider this:

See the 10 stocks »

*Stock Advisor returns as of October 27, 2025

Ally is an advertising partner of Motley Fool Money. American Express is an advertising partner of Motley Fool Money. Bank of America is an advertising partner of Motley Fool Money. Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Apple, Berkshire Hathaway, Chevron, D.R. Horton, Domino's Pizza, Jefferies Financial Group, Lennar, Mastercard, Moody's, NVR, VeriSign, and Visa. The Motley Fool recommends Capital One Financial, Constellation Brands, Diageo Plc, Heico, Kroger, Occidental Petroleum, and UnitedHealth Group. The Motley Fool has a disclosure policy.

Original Article on Source

Source: "AOL Money"

Source: Money

Published: November 03, 2025 at 11:18AM on Source: ONEEL MAG

#ShowBiz#Sports#Celebrities#Lifestyle

byLiam Oneel

in

November 03, 2025

Here Are All 46 Stocks Warren Buffett Holds for Berkshire Hathaway's $313 Billion Portfolio

Here Are All 46 Stocks Warren Buffett Holds for Berkshire Hathaway's $313 Billion Portfolio Justin Pope, The Motl...

ONEEL JRNL

BenDeLaCreme and Kennedy Davenport recall chaos after RuPaul's Drag Race All Stars 3 self-elimination

byLiam Oneel

in

November 03, 2025

BenDeLaCreme and Kennedy Davenport recall chaos after RuPaul's Drag Race All Stars 3 self-elimina...

Vampire Diaries creators talk season 1's Katherine twist, the fan response that left them 'aghast'

byLiam Oneel

in

November 03, 2025

Vampire Diaries creators talk season 1's Katherine twist, the fan response that left them 'aghast'

byLiam Oneel

in

November 03, 2025

If You'd Invested $1,000 in Nvidia 5 Years Ago, Here's How Much You'd Have Today

byLiam Oneel

in

November 03, 2025

Prediction: The Next Eli Lilly Might Already Be Trading Under $50

byLiam Oneel

in

November 03, 2025

Is Berkshire Hathaway Stock a Buy Now?

byLiam Oneel

in

November 03, 2025

Is TransCrypts Riding the Next Wave of AI Infrastructure? 3 Reasons Tech Investors Will Want to Keep an Eye on This Startup.

byLiam Oneel

in

November 03, 2025

Here Are All 46 Stocks Warren Buffett Holds for Berkshire Hathaway's $313 Billion Portfolio

Search This Blog

Blog Archive

Total Pageviews

Popular Posts